Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?

Por Vingerhoets, Wilhelmina A. M., Bloemen, Oswald J. N., Bakker, Geor, van Amelsvoort, Therese A. M. J.
Publicado em 2013

Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome

Por Evers, Laurens J. M., van Amelsvoort, Therese A. M. J., Bakker, Jaap A., de Koning, Mariken, Drukker, Marjan, Curfs, Leopold M. G.
Publicado no Psychopharmacology (Berl) (2015)

Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome

Por van Beveren, Nico J. M., Krab, Lianne C., Swagemakers, Sigrid, Buitendijk, Gabriella, Boot, Erik, van der Spek, Peter, Elgersma, Ype, van Amelsvoort, Therese A. M. J.
Publicado em 2012

Correction: Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome

Por van Beveren, Nico J. M., Krab, Lianne C., Swagemakers, Sigrid, Buitendijk, Gabriëe H.S., Boot, Erik, van der Spek, Peter, Elgersma, Ype, van Amelsvoort, Therese A. M. J.
Publicado em 2012

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion...

Por Bakker, Geor, Caan, Matthan W. A., Vingerhoets, Wilhelmina A. M., da Silva- Alves, Fabiana, de Koning, Mariken, Boot, Erik, Nieman, Dorien H., de Haan, Lieuwe, Bloemen, Oswald J., Booij, Jan, van Amelsvoort, Thérèse A. M. J.
Publicado no PLoS One (2016)